Editorial.

Autor: Wiznerowicz M; Laboratory for Gene Therapy at the Greater Poland Cancer Center, Poznan, Poland; Deparment of Cancer Immunology, Chair of Medical Biotechnology at the Poznan University of Medical Sciences, Poznan, Poland., Shah PK; Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center, Houston, TX, USA., Andersen JN; Institute for Applied Cancer Science at the University of Texas MD Anderson Cancer Center, Houston, TX, USA; XTuit Pharmaceuticals, Inc., Boston, MA, USA.
Jazyk: angličtina
Zdroj: Contemporary oncology (Poznan, Poland) [Contemp Oncol (Pozn)] 2015; Vol. 19 (1A), pp. 1-2. Date of Electronic Publication: 2015 Jan 20.
DOI: 10.5114/wo.2015.48671
Databáze: MEDLINE